These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23603779)

  • 1. Fetal fibronectin test on Chinese women with symptoms of preterm labour: a pilot study.
    Cheung KW; Ngu SF; Lee CP
    Hong Kong Med J; 2013 Oct; 19(5):424-8. PubMed ID: 23603779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
    Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
    BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predicating imminent preterm labour based on a determination of foetal fibronectin in a vaginal smear].
    Wilms FF; van Stralen G; Porath MM; Papatsonis DN; Oei SG; Mol BW; Scherjon S
    Ned Tijdschr Geneeskd; 2009; 153():B398. PubMed ID: 19785869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary results of fetal fibronectin testing in twin pregnancies].
    Markova I; Nikolov A; Markov P
    Akush Ginekol (Sofiia); 2014; 53(6):4-8. PubMed ID: 25993735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?
    van Baaren GJ; Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvanck BW; van Eijck J; Franssen MT; Sollie KM; Vandenbussche FP; Woiski M; Bossuyt PM; Opmeer BC; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():79-85. PubMed ID: 26182836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sequential use of cervical length measurement before fetal fibronectin detection to predict spontaneous preterm delivery in women with preterm labor].
    Deplagne C; Maurice-Tison S; Coatleven F; Vandenbossche F; Horovitz J
    J Gynecol Obstet Biol Reprod (Paris); 2010 Nov; 39(7):575-83. PubMed ID: 20884131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).
    Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HC; Bloemenkamp KW; Bolte AC; Cornette J; Derks JB; Duvekot JJ; van Eyck J; Kwee A; Opmeer BC; van Pampus MG; Lotgering FK; Scherjon SA; Sollie KM; Spaanderman ME; Willekes C; van der Post JA; Mol BW
    BMC Pregnancy Childbirth; 2009 Sep; 9():38. PubMed ID: 19723320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor.
    Schmitz T; Maillard F; Bessard-Bacquaert S; Kayem G; Fulla Y; Cabrol D; Goffinet F
    Am J Obstet Gynecol; 2006 Jan; 194(1):138-43. PubMed ID: 16389023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
    Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J
    Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of fetal fibronectin for predicting preterm birth.
    Swamy GK; Simhan HN; Gammill HS; Heine RP
    J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of cervical fibronectin to predict premature delivery in a population of monofetal pregnancies with idiopathic preterm labor.
    Voluménie JL; Guibourdenche J; Doridot V; Sibony O; Oury JF; Blot P; Luton D
    Eur J Obstet Gynecol Reprod Biol; 2001 Jul; 97(1):35-9. PubMed ID: 11435006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients.
    Skoll A; St Louis P; Amiri N; Delisle MF; Lalji S
    J Obstet Gynaecol Can; 2006 Mar; 28(3):206-213. PubMed ID: 16650359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is fetal fibronectin a valid test predictive of premature labor?].
    Mansouri A; Tadjerouni A; El Rabiey G; Baube S; Garnier G; Tribalat S
    Contracept Fertil Sex; 1997 May; 25(5):380-4. PubMed ID: 9273109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Marek S; Hellmeyer L; Reitz D; Schmidt S
    Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY; Seto MTY; Lewis H; Cheung KW
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting preterm birth: a cost-effectiveness analysis.
    Mozurkewich EL; Naglie G; Krahn MD; Hayashi RH
    Am J Obstet Gynecol; 2000 Jun; 182(6):1589-98. PubMed ID: 10871482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.